https://www.thestar.com.my/news/nation/2021/04/18/covid-19-number-of-infected-health-workers-10-times-lower-after-vaccination-says-mosti

"The total of 40 health workers infected with Covid-19 compared to 438,000 individuals who have completed two doses of the vaccine is a very small percentage.

"This is because 99.9% of the individuals who have completed the two doses of the vaccine are not infected even though they are frontline workers who deal with Covid-19 patients on a daily basis," he said in a statement on Sunday (April 18).

https://www.freemalaysiatoday.com/category/nation/2021/04/18/admit-failure-and-change-approach-to-curb-covid-19-think-tank-tells-govt/

“With a survival rate of 99.63%, Malaysia is scoring well. But now we need to focus on a protection strategy for those who fall into the 0.37% mortality rate.

Ferlito warned that delay in returning to normality, including travelling, will have a major impact, especially on the poorer segments of the population, adding that lockdowns are regressive.

Hidden Gem has been discovered.....MAHSING.

Don't miss the boat.

After 2nd April, ASB has not sold anything till 13th April, when it sold small amount 414,600 shares.

https://klse.i3investor.com/insider/substantialShareholder/1155/06-Apr-2021/513139_792029483.jsp

https://klse.i3investor.com/insider/substantialShareholder/1155/15-Apr-2021/513805_3125262883.jsp

This is for long term hold and not for short term trading.

Dividend yield better than FD, ASM and ASB.

Very boring but safe....can sleep peacefully at night.

IBs covering the stock....all have BUY call with TP ranging from 1.02 to 1.28.....

.....when it gets bullish, probably it will hit above IB TP.

Nice....ATK is back.

@choysun....cheers...

https://www.theedgemarkets.com/article/maybank-says-fiveyear-strategy-...

TA Securities Holdings Bhd analyst Wong Li Hsia said TA foresees robust earnings growth potential for Maybank, thanks to its established regional presence, which will allow the bank to tap into rising ASEAN trade and cross-border opportunities.

"[There is] no change to our earnings estimates (for Maybank). We maintain Maybank’s TP at RM10.80. Our valuation is based on an implied P/BV (price-to-book value) of about 1.38 times based on the Gordon Growth Model. With that, we reiterate our 'buy' recommendation on the stock,” she said.

https://klse.i3investor.com/servlets/ptres/59261.jsp

MAYBANK is our Top Pick for the banking sector for its most favourable risk-to- reward with the highest dividend yield in the industry paired by solid ROE prospects. Its market leading position in loans and deposits should prove beneficial in an economic recovery phase while its CASA-to-deposit ratio of c.40% would ease access to funds.

Maintain OUTPERFORM with a higher TP of RM10.60 (from RM8.75).

ANOTHER VERY GOOD RECOVERY STOCK.....

https://www.malaymail.com/news/money/2021/04/12/research-firms-remain-...

By end-2025, the group aims to achieve a return on equity of between 13 per cent and 15 per cent, cost-income (CI) ratio of not more than 45 per cent, earnings per share of over 100 sen and dividend payout ratio of up to 60 per cent.

AmInvestment Bank has maintained its “Buy” call on Maybank with a revised fair value of RM10.10 per share from RM9.80 previously. RHB Investment Bank has also kept its “Buy” call on Maybank with a 20.6 per cent upside on the target price at RM10.

@choysun.......hahaha

https://www.theedgemarkets.com/article/maybank-says-fiveyear-strategy-m25-anchored-three-priorities

TA Securities Holdings Bhd analyst Wong Li Hsia said TA foresees robust earnings growth potential for Maybank, thanks to its established regional presence, which will allow the bank to tap into rising ASEAN trade and cross-border opportunities.

"[There is] no change to our earnings estimates (for Maybank). We maintain Maybank’s TP at RM10.80. Our valuation is based on an implied P/BV (price-to-book value) of about 1.38 times based on the Gordon Growth Model. With that, we reiterate our 'buy' recommendation on the stock,” she said.

https://www.theedgemarkets.com/article/maybank-says-fiveyear-strategy-m25-anchored-three-priorities

TA Securities Holdings Bhd analyst Wong Li Hsia said TA foresees robust earnings growth potential for Maybank, thanks to its established regional presence, which will allow the bank to tap into rising ASEAN trade and cross-border opportunities.

"[There is] no change to our earnings estimates (for Maybank). We maintain Maybank’s TP at RM10.80. Our valuation is based on an implied P/BV (price-to-book value) of about 1.38 times based on the Gordon Growth Model. With that, we reiterate our 'buy' recommendation on the stock,” she said.

https://klse.i3investor.com/servlets/ptres/59261.jsp

MAYBANK is our Top Pick for the banking sector for its most favourable risk-to- reward with the highest dividend yield in the industry paired by solid ROE prospects. Its market leading position in loans and deposits should prove beneficial in an economic recovery phase while its CASA-to-deposit ratio of c.40% would ease access to funds.

Maintain OUTPERFORM with a higher TP of RM10.60 (from RM8.75).

https://www.malaymail.com/news/money/2021/04/12/research-firms-remain-upbeat-on-maybank/1965835

By end-2025, the group aims to achieve a return on equity of between 13 per cent and 15 per cent, cost-income (CI) ratio of not more than 45 per cent, earnings per share of over 100 sen and dividend payout ratio of up to 60 per cent.

AmInvestment Bank has maintained its “Buy” call on Maybank with a revised fair value of RM10.10 per share from RM9.80 previously. RHB Investment Bank has also kept its “Buy” call on Maybank with a 20.6 per cent upside on the target price at RM10.

https://www.malaymail.com/news/money/2021/04/12/research-firms-remain-upbeat-on-maybank/1965835

By end-2025, the group aims to achieve a return on equity of between 13 per cent and 15 per cent, cost-income (CI) ratio of not more than 45 per cent, earnings per share of over 100 sen and dividend payout ratio of up to 60 per cent.

AmInvestment Bank has maintained its “Buy” call on Maybank with a revised fair value of RM10.10 per share from RM9.80 previously. RHB Investment Bank has also kept its “Buy” call on Maybank with a 20.6 per cent upside on the target price at RM10.

For comparison......

MAYBANK is our Top Pick for the banking sector for its most favourable risk-to- reward with the highest dividend yield in the industry paired by solid ROE prospects. Its market leading position in loans and deposits should prove beneficial in an economic recovery phase while its CASA-to-deposit ratio of c.40% would ease access to funds.

https://klse.i3investor.com/servlets/ptres/59261.jsp

The fixing of DRP price is based on average closing price.....and closing price is determined by market forces.....to make the price close low is sap sap sui for BIG funds.

Yes correct. ASB own 4+ billion shares.

Big funds want the DRP price to be fixed low....will make sure price close low during these few days.....

After ex dividend, the price will drop accordingly.....if the current price holds till ex date, after ex it will be below 8

DRP price will probably be fixed after AGM on 15-4-21.....price will remain low....no need to chase high.

Looked at how it was traded recently....it seems operator are starting to collect only.....

....don't miss the boat and wait for them to collect enough.

Posted by fregend > Mar 30, 2021 12:20 PM | Report Abuse

wake me up when it hit 0.90

---------------------------------------------------------------------

wake up.....WAKE UP !!!!!

DRP is not fixed....why need to closed so high today? :(

https://www.theedgemarkets.com/article/after-rising-40-year-ago-genting-still-worth-bet

Genting has 12 “buy” calls and five “hold” recommendations, with an average target price of RM6.13 – which means a 17.88% upside from yesterday’s closing.

Looking ahead, analysts and fund managers are of the opinion that this high paying dividend could be the trend for the Genting Group.

“I think they will continue paying higher dividends as earnings will improve now,” the analyst added.

Yes, no need to bid high....price will remain low until DRP price is fixed.

The dividend reinvestment price will probably be announced after AGM on 15-4-21......during this period, prices will probably remain low.

Numbawan recovery play !

apple168 now calling TP for TG at 1.50....wakaka laugh die me....

Yes....going back to where it should be.....down...before DRP price is fixed.

Wow...TG big support at 4.80....Broken !

All gloves, at current price, cry no tears for those holding....

I want to have peaceful sleep at night.

MBB is my numbawan holding....dividend yield 6-7 %.....better than my fixed income ASM.

https://www.thestar.com.my/business/business-news/2021/03/30/recovery-in-sight-for-property-market-by-2h21

Possibly the new theme play in the next few months...be early to get on board.

A good buy...for consideration...

KUALA LUMPUR (March 30): RHB Research Institute has maintained "buy" on Mah Sing Group Bhd at 82 sen with a higher target price (TP) of RM1.02 (from 97 sen) as it foresees the group’s maiden glove manufacturing business to boost its earnings.

She opined that the contribution from glove manufacturing could possibly boost the group’s FY21 earnings by 70% to 80%.

“Given the earnings boost and its 40% dividend payout policy, we expect the dividend per share to amount to 4.6 sen and 6.3 sen for FY21 to FY22, suggesting an attractive yield of 6% to 8%, among the highest in the property sector,” she said, adding that investors should turn more confident in the group’s glove manufacturing business.
https://www.theedgemarkets.com/article/rhb-research-raises-mah-sing-ta...


Disclaimer : I do own the stock.

A good buy...for consideration...

KUALA LUMPUR (March 30): RHB Research Institute has maintained "buy" on Mah Sing Group Bhd at 82 sen with a higher target price (TP) of RM1.02 (from 97 sen) as it foresees the group’s maiden glove manufacturing business to boost its earnings.

She opined that the contribution from glove manufacturing could possibly boost the group’s FY21 earnings by 70% to 80%.

“Given the earnings boost and its 40% dividend payout policy, we expect the dividend per share to amount to 4.6 sen and 6.3 sen for FY21 to FY22, suggesting an attractive yield of 6% to 8%, among the highest in the property sector,” she said, adding that investors should turn more confident in the group’s glove manufacturing business.
https://www.theedgemarkets.com/article/rhb-research-raises-mah-sing-ta...


Disclaimer : I do own the stock.

@DestinyL....one cheap stock for your attention...

KUALA LUMPUR (March 30): RHB Research Institute has maintained "buy" on Mah Sing Group Bhd at 82 sen with a higher target price (TP) of RM1.02 (from 97 sen) as it foresees the group’s maiden glove manufacturing business to boost its earnings.

She opined that the contribution from glove manufacturing could possibly boost the group’s FY21 earnings by 70% to 80%.

“Given the earnings boost and its 40% dividend payout policy, we expect the dividend per share to amount to 4.6 sen and 6.3 sen for FY21 to FY22, suggesting an attractive yield of 6% to 8%, among the highest in the property sector,” she said, adding that investors should turn more confident in the group’s glove manufacturing business.
https://www.theedgemarkets.com/article/rhb-research-raises-mah-sing-target-price-rm102-venture-glove-manufacturing-business

KUALA LUMPUR (March 30): RHB Research Institute has maintained "buy" on Mah Sing Group Bhd at 82 sen with a higher target price (TP) of RM1.02 (from 97 sen) as it foresees the group’s maiden glove manufacturing business to boost its earnings.

She opined that the contribution from glove manufacturing could possibly boost the group’s FY21 earnings by 70% to 80%.

“Given the earnings boost and its 40% dividend payout policy, we expect the dividend per share to amount to 4.6 sen and 6.3 sen for FY21 to FY22, suggesting an attractive yield of 6% to 8%, among the highest in the property sector,” she said, adding that investors should turn more confident in the group’s glove manufacturing business.

https://www.theedgemarkets.com/article/rhb-research-raises-mah-sing-target-price-rm102-venture-glove-manufacturing-business

https://www.cnbc.com/2021/03/29/cdc-study-shows-single-dose-of-pfizer-or-moderna-covid-vaccines-was-80percent-effective.html

HEALTH AND SCIENCE
One dose of Pfizer or Moderna vaccines was 80% effective in preventing Covid in CDC study of health workers

Malaysia was missing from the CNBC Asia index the whole day....has just been restored....may be that caused some uncertainty.....

@apple168...how is your gloves doing?

Congratulation to you for holding gloves.

@apple168...how is your gloves doing?

Congratulation to you for holding gloves.

Wow...week 15-19 March...the trading range was 5.05-5.53

Yes I am still collecting....will buy on Thursday...withdrawing ASM at the end of month, lose one month dividend....hope the boat will wait....

https://www.thestar.com.my/business/business-news/2021/03/27/a-market-flush-with-liquidity

He sees opportunities in Southeast Asia and thinks valuations of financials in emerging markets are relatively attractive.

A prolonged rotation into value stocks requires a positive earnings cycle and higher expectations for inflation, said Jing Ning, a portfolio manager for Fidelity’s China Focus Fund. “There are some signs these shifts are taking hold.”

He sees opportunities in Southeast Asia and thinks valuations of financials in emerging markets are relatively attractive.

A prolonged rotation into value stocks requires a positive earnings cycle and higher expectations for inflation, said Jing Ning, a portfolio manager for Fidelity’s China Focus Fund. “There are some signs these shifts are taking hold.”

https://www.theedgemarkets.com/article/sizzling-asia-value-rally-has-fund-managers-hunting-gems

Asia value stocks have outperformed their growth counterparts by almost eight percentage points this quarter. That’s the most since the dotcom bubble burst. Vaccine rollouts, a spike in US Treasury yields and economic recovery expectations spurred a rally in 2020’s losers, sending stocks like Japanese banks and Macau casinos back to their pre-pandemic levels.

“We agree a lot of the ‘reopening’ stocks have bounced very hard, but there are some pockets of opportunity that continue to be attractive,” said Ernest Yeung, a portfolio manager at T Rowe Price. His Emerging Markets Discovery Stock Fund beat 97% of peers this year.